Hematoporphyrin-based photodynamic therapy for cutaneous squamous cell carcinoma in cats

Photodynamic therapy (PDT) using a haematoporphyrin derivative (Photogem (R), General Physics Institute and clustes Ltda) as photosensitizer and light emitting diodes (LEDs) as the light source was evaluated in 12 cats with cutaneous squamous cell carcinoma. Lesions were illuminated with LEDs, (300 J/cm for 30 min) 24 h after the administration of the photosensitizer. Clinical responses were classified as complete disappearance of the tumour with total re-epithelialization; partial response (a reduction greater than 50%); and no response (less than 50% reduction). Tumours localized to the pinna treated with one (n = 3) or two (n = 4) applications of PDT yielded no response. Highly invasive tumours of the nose and nasal planum also showed no response, after two treatments (n = 2). A combination of PDT and surgery was performed in three cases. Two cats showed partial response and one complete response with one application of therapy 30 days after nasal surgery. Small and noninfiltrative lesions (n = 3) of the nasal planum showed a PR with one application (n = 2) and a CR with two applications (n = 1). This study shows that PDT using Photogem (R) and LEDs can provide local control of low-grade feline squamous cell carcinoma. The addition of PDT to surgery in more invasive cases may help prevent recurrence.

As características da repercussão geral e dos recursos repetitivos nas decisões tributárias: na divergência de entendimento dos tribunais superiores

O trabalho se presta a identificar semelhanças entre o instituto da Repercussão Geral, nos recursos extraordinários interpostos perante o Supremo Tribunal Federal, e do Recurso Repetitivo, nos recursos especiais interpostos perante o Superior Tribunal de Justiça. Com isso, é realizada uma tentativa de busca jurisprudencial até o fim de 2009, não obtendo êxito na busca dos julgados em Direito Tributário, para identificar uma possível contradição entre o entendimento dos fundamentos dos filtros recursais entre as Cortes Superiores. Por fim, há uma análise crítica sobre as possíveis interferências do julgamento do STJ nos julgamentos do STF, procurando compreender o papel do Supremo, bem como as possíveis conseqüências das decisões do STF nos contribuintes e suas formas de defesa possíveis, caso venha ocorrer a hipótese formulada no trabalho.

Hematoporphyrin-based photodynamic therapy for cutaneous squamous cell carcinoma in cats

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Radioisotopes in industry training program.

"Designed specifically to teach professional industrial personnel the basic considerations in the application of radioisotopes to industrial work."

Degree program. Fifth-year project study reports and graduate theses 1946-1951.

Mode of access: Internet.

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

BACKGROUND: Uveal melanoma exhibits a high incidence of metastases; and, to date, there is no systemic therapy that clearly improves outcomes. The anticytotoxic T-lymphocyte-associated protein 4 (anti-CTLA-4) antibody ipilimumab is a standard of care for metastatic melanoma; however, the clinical activity of CTLA-4 inhibition in patients with metastatic uveal melanoma is poorly defined. METHODS: To assess ipilimumab in this setting, the authors performed a multicenter, retrospective analysis of 4 hospitals in the United States and Europe. Clinical characteristics, toxicities, and radiographic disease burden, as determined by central, blinded radiology review, were evaluated. RESULTS: Thirty-nine patients with uveal melanoma were identified, including 34 patients who received 3 mg/kg ipilimumab and 5 who received 10 mg/kg ipilimumab. Immune-related response criteria and modified World Health Organization criteria were used to assess the response rate (RR) and the combined response plus stable disease (SD) rate after 12 weeks, after 23 weeks, and overall (median follow-up, 50.4 weeks [12.6 months]). At week 12, the RR was 2.6%, and the response plus SD rate was 46.%; at week 23, the RR was 2.6%, and the response plus SD rate was 28.2%. There was 1 complete response and 1 late partial response (at 100 weeks after initial SD) for an immune-related RR of 5.1%. Immune-related adverse events were observed in 28 patients (71.8%) and included 7 (17.9%) grade 3 and 4 events. Immune-related adverse events were more frequent in patients who received 10 mg/kg ipilimumab than in those who received 3 mg/kg ipilimumab. The median overall survival from the first dose of ipilimumab was 9.6 months (95% confidence interval, 6.3-13.4 months; range, 1.6-41.6 months). Performance status, lactate dehydrogenase level, and an absolute lymphocyte count ≥ 1000 cells/μL at week 7 were associated significantly with survival. CONCLUSIONS: In this multicenter, retrospective analysis of 4 hospitals in the United States and Europe of patients with uveal melanoma, durable responses to ipilimumab and manageable toxicity were observed.

History and general catalogue of LaGrange Collegiate Institute : situated at Ontario, LaGrange Co., Ind.

Mode of access: Internet.

Quadrennial address of the bishops of the Colored Methodist Episcopal Church to the fourteenth session of the General Conference : held in Saint Louis, Missouri, May third, one thousand nine hundred and twenty two.

Signed at end: Isaac Lane (retired). Robert Simeon Williams. Elias Cottrell. Charles Henry Phillips. Randall Albert Carter. Nelson Caldwell Cleaves.